RGS22 Rabbit Polyclonal Antibody

Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RGS22 . This antibody is tested and proven to work in the following applications:

Description: A Rabbit Polyclonal antibody against RGS22 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

Description: A Rabbit Polyclonal antibody against RGS22 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

Description: RGS22 Antibody: Regulator of G-protein signaling (RGS) proteins contain an 120 amino acid conserved domain, termed the RGS domain, that acts as a GTPase-activating protein that acts to reduce the signal transmitted by the receptor-activated G-alpha subunit. RGS22 is a recently identified member of this family that localizes to the testis and can interact with guanine nucleotide binding proteins alpha 11, 12, and 13 (GNA11, GNA12, and GNA13). While RGS22 has been postulated to play a role in spermiogenesis in the testis, it is also expressed in several cancer cell lines with an epithelial origin and associated with cancer metastasis. Its overexpression in a highly metastatic cancer causes a decrease in cell migration and a reduction of the invasive potential of the cells, suggesting that RGS22 may be a potential prognostic biomarker for metastasis.

Description: RGS22 Antibody: Regulator of G-protein signaling (RGS) proteins contain an 120 amino acid conserved domain, termed the RGS domain, that acts as a GTPase-activating protein that acts to reduce the signal transmitted by the receptor-activated G-alpha subunit. RGS22 is a recently identified member of this family that localizes to the testis and can interact with guanine nucleotide binding proteins alpha 11, 12, and 13 (GNA11, GNA12, and GNA13). While RGS22 has been postulated to play a role in spermiogenesis in the testis, it is also expressed in several cancer cell lines with an epithelial origin and associated with cancer metastasis. Its overexpression in a highly metastatic cancer causes a decrease in cell migration and a reduction of the invasive potential of the cells, suggesting that RGS22 may be a potential prognostic biomarker for metastasis.

Description: Rabbit polyclonal RGS22 antibody raised against the N terminal of RGS22

Description: A polyclonal antibody against RGS22. Recognizes RGS22 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

Description: A polyclonal antibody against RGS22. Recognizes RGS22 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100

Description: A polyclonal antibody against RGS22. Recognizes RGS22 from Human. This antibody is Unconjugated. Tested in the following application: ELISA

Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RGS22 (N-Terminus). This antibody is tested and proven to work in the following applications:

Description: Unconjugated Rabbit polyclonal to RGS22

Description: (NT) RGS22 peptide

Description: A polyclonal antibody against RGS22. Recognizes RGS22 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

Description: A polyclonal antibody against RGS22. Recognizes RGS22 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

Description: A polyclonal antibody against RGS22. Recognizes RGS22 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RGS22 antibody, catalog no. 70R-3489

Description: A cloning plasmid for the RGS22 gene.

Description: A cloning plasmid for the RGS22 gene.